NASDAQ$PETS

PetMed Express · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

Reported an 11% increase in revenue and a net loss for Q3 2024, with the completion of the financial restatement.

PetMed Express reported an 11% increase in revenue to $65.3 million for the third quarter of fiscal year 2024, driven by the acquisition of PetCareRx, offset by declines in PetMeds legacy sales. However, the company experienced a net loss of $2.0 million, or $(0.10) per diluted share, compared to a net loss of $212 thousand, or $(0.01) per diluted share, in the prior year quarter. The company's cash position remains strong at $49.4 million, and they are now current in all SEC filings following the completion of their financial restatement.

  • Net sales increased by 11% year over year to $65.3 million, driven by the acquisition of PetCareRx.
  • Net loss was $2.0 million, or $(0.10) per diluted share, compared to a net loss of $212 thousand, or $(0.01) per diluted share, for the prior year quarter.
  • Adjusted EBITDA was $924 thousand, compared to $2.7 million for the quarter ended December 31, 2022.
  • Cash on hand was $49.4 million with no debt.

Headline financials

Total Revenue

$65.3M

Previous: $58.9M+11.0%
EPS

-$0.10

Previous: $0.02-600.0%
Capital Expenditures

-$3.26M

Previous: -$3.33M+2.1%
Free Cash Flow

-$6.07M

Previous: $14.8M-141.1%
Net Income

-$2.03M

Previous: -$19K-10568.4%
Operating Income

-$3.07M

Previous: -$769K-299.7%
Gross Profit

$17.9M

Previous: $15.2M+17.4%
Stock-Based Comp

$1.71M

Previous: $1.77M-3.6%

Revenue & EPS history

PetMed Express · Revenue · Quarterly

$65.3M

Q3 2024+11%vs Q3 2023
Beat estimate in 3 of 14 quarters(21%)
ActualEstimate

Forward guidance

No specific forward guidance was provided in the earnings report.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.0%

Avg return

Earnings day

-1.6%

Avg return

5 days after

-0.4%

Avg return

30 days after

42%

27 / 65 earnings

Positive

+40.8%

Q2 2020

Best reaction

-26.4%

Q2 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-16.4%-21.1%
Q3 2026-3.6%-8.7%-15.5%
Q4 2025+0.0%-4.9%-6.6%
Q2 2026-1.4%-2.7%-8.2%
Q1 2026-1.1%-1.4%-6.9%
Q3 2025-14.8%-20.1%-22.7%
Q2 2025+34.5%+27.2%+35.0%
Q1 2025-11.0%-13.0%-4.5%
Q4 2024-0.7%-1.7%-7.4%
Q3 2024+0.2%-1.2%+8.9%
Q2 2024-26.4%-23.0%-22.6%
Q1 2024-2.8%-6.4%-20.0%
Q4 2023+6.7%+1.0%-6.6%
Q3 2023-11.1%-13.3%-19.6%
Q2 2023-10.5%-4.7%-15.5%
Q1 2023+4.3%+4.2%+0.9%
Q4 2022+6.9%+2.0%+3.0%
Q3 2022+7.2%+7.7%+3.4%
Q2 2022+5.1%+5.1%+5.2%
Q1 2022+7.1%+13.0%+3.2%
Q4 2021+2.8%+0.5%+56.5%
Q3 2021-14.3%-11.1%+3.2%
Q2 2021-2.2%-3.5%-1.9%
Q1 2021-16.0%-23.8%-17.4%
Q4 2020+3.6%-4.0%-7.5%
Q3 2020-11.0%-11.2%+4.0%
Q2 2020+40.8%+32.8%+21.7%
Q1 2020+2.5%-1.5%+5.1%
Q4 2019-9.0%-9.7%-18.9%
Q3 2019-6.2%-3.4%-3.1%
Q2 2019+2.6%+1.1%-9.7%
Q1 2019-13.0%-11.8%-6.4%
Q4 2018-0.9%+1.4%+15.1%
Q3 2018-4.8%-10.2%-12.0%
Q2 2018+4.4%-5.0%+9.0%
Q1 2018+18.6%+19.3%-10.7%
Q4 2017+34.7%+41.2%+48.4%
Q3 2017-5.1%-5.4%-3.6%
Q2 2017-3.2%-4.0%+6.6%
Q1 2017+6.0%+5.8%+3.3%
Q4 2016+2.9%
Q3 2016-4.8%
Q2 2016+2.1%
Q1 2016+0.5%
Q4 2015+2.6%
Q3 2015+14.3%
Q2 2015-3.7%
Q1 2015+5.0%
Q4 2014+1.6%
Q3 2014-12.0%
Q2 2014-10.3%
Q1 2014+12.7%
Q4 2013-0.5%
Q3 2013+7.0%
Q2 2013+6.9%
Q1 2013-16.3%
Q4 2012-5.4%
Q4 2010-5.4%
Q3 2011-0.2%
Q3 2012-0.2%
Q2 2012-0.8%
Q2 2011-0.8%
Q1 2012-0.1%
Q1 2011-0.1%
Q4 2011-0.1%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro